3 results
Approved WMOCompleted
Primary objectiveTo evaluate and compare the single-dose pharmacokinetic of turoctocog alfa pegol from the pivotal process with turoctocog alfa pegol from the commercial process, each given as intravenous administrations of 50 U/kg to patients with…
Approved WMOPending
To evaluate the safety and tolerability of crovalimab compared witheculizumab
Approved WMOPending
To evaluate the efficacy of crovalimab compared to eculizumab